Lexaria Bioscience Current Cash

Lexaria Bioscience (LEXX) currently reports a current cash of $3.5M as of May 2026. That compares with $4.6M in the prior-year period — down 24.3% year over year. Use the charts on this page to explore Lexaria Bioscience's current cash history and peer comparisons.

Lexaria Bioscience's current cash decreased from $4.6M to $3.5M — a 24.3% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexaria Bioscience reported $3.5M in current cash as of May 2026. That compares with $4.6M in the prior-year period — down 24.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $3.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexaria Bioscience, and consider following LEXX for alerts when major investors trade the stock.

Lexaria Bioscience is classified in the Healthcare sector. On current cash, it currently shows $3.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LEXX with unrelated industries.